Director sold ~$195K of Teradyne
Scheduled in advanceTraded Apr 8, 2026 · Filed Apr 9, 2026
Teradyne's President, Product Test sold $5.5K of Teradyne shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$5,475
Shares × reported transaction price
64 days after results of Feb 3, 2026, 21 days before results of Apr 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $358.29 on Apr 8, 2026, at its 52-week high, after a 9% rise over the previous 30 trading days
52-week range $69.81 (Apr 21, 2025) to $358.29 (Apr 8, 2026), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $329.09 on Feb 24, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.4% | +4.5% | -1.1% |
| 30 days | -0.4% | +8.8% | -9.2% |
| 90 days | -1.4% | +10.6% | -12.1% |
Past results only. Not a forecast.
Director sold ~$195K of Teradyne
Scheduled in advanceRoutine share withholding; mechanical by default.
Routine share withholding; mechanical by default.